OraSure reported Q4 revenues of $63.6 million, beating analysts' average expectation of $62.0 million and the high end of previous guidance of $60 million to $63 million.
31.01.2022 - Data Demonstrates InteliSwab is Accurate, Easy to Use, and Well Accepted by Children BETHLEHEM, Pa., Jan. 31, 2022 (GLOBE NEWSWIRE) - OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and . Seite 1